199 related articles for article (PubMed ID: 29227418)
1. Development and Validation of Surveillance-Based Algorithms to Estimate Hepatitis C Treatment and Cure in New York City.
Moore MS; Bocour A; Jordan L; McGibbon E; Varma JK; Winters A; Laraque F
J Public Health Manag Pract; 2018; 24(6):526-532. PubMed ID: 29227418
[TBL] [Abstract][Full Text] [Related]
2. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017.
Moore MS; Bocour A; Laraque F; Winters A
Public Health Rep; 2018; 133(4):497-501. PubMed ID: 29902392
[TBL] [Abstract][Full Text] [Related]
3. Use of Capture-Recapture Analysis to Assess Reporting Completeness of Births to Hepatitis B-Positive Women in New York City, 2013-2014.
Devinney K; Lazaroff J; Rosen JB; Zimmerman CM; Zucker JR
Public Health Rep; 2020; 135(3):322-328. PubMed ID: 32267800
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance-based propensity score matching approach.
Deming R; Ford MM; Moore MS; Lim S; Perumalswami P; Weiss J; Wyatt B; Shukla S; Litwin A; Reynoso S; Laraque F
J Viral Hepat; 2018 Nov; 25(11):1236-1243. PubMed ID: 29757491
[TBL] [Abstract][Full Text] [Related]
5. Field investigations of emergency department syndromic surveillance signals--New York City.
Steiner-Sichel L; Greenko J; Heffernan R; Layton M; Weiss D
MMWR Suppl; 2004 Sep; 53():184-9. PubMed ID: 15717390
[TBL] [Abstract][Full Text] [Related]
6. Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.
Ford MM; Jordan AE; Johnson N; Rude E; Laraque F; Varma JK; Hagan H
J Public Health Manag Pract; 2018; 24(1):41-48. PubMed ID: 28141668
[TBL] [Abstract][Full Text] [Related]
7. Estimating the prevalence of chronic hepatitis C virus infection in New York City, 2015.
Bocour A; Greene SK; Laraque F; Winters A
Epidemiol Infect; 2018 Sep; 146(12):1537-1542. PubMed ID: 29932040
[TBL] [Abstract][Full Text] [Related]
8. Detection of Recurrent Hepatitis C Viremia Using Surveillance Data, New York City.
Guerra K; Bocour A; Moore MS; Winters A
J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):126-129. PubMed ID: 32956285
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian evidence synthesis approach to estimate disease prevalence in hard-to-reach populations: hepatitis C in New York City.
Tan S; Makela S; Heller D; Konty K; Balter S; Zheng T; Stark JH
Epidemics; 2018 Jun; 23():96-109. PubMed ID: 29666018
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for chronic hepatitis B virus infection - New York City, June 2008-November 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(1):6-9. PubMed ID: 22237029
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
[TBL] [Abstract][Full Text] [Related]
12. Disparities in Zika Virus Testing and Incidence Among Women of Reproductive Age-New York City, 2016.
Lee CT; Greene SK; Baumgartner J; Fine A
J Public Health Manag Pract; 2018; 24(6):533-541. PubMed ID: 29084118
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users.
Campbell AN; Des Jarlais D; Hannah C; Braunstein S; Tross S; Kersanske L; Borges C; Pavlicova M; Jefferson K; Newville H; Weaver L; Wolff M
BMC Health Serv Res; 2016 Aug; 16(a):341. PubMed ID: 27485435
[TBL] [Abstract][Full Text] [Related]
14. A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.
Behrends CN; Eggman AA; Gutkind S; Bresnahan MP; Fluegge K; Laraque F; Litwin AH; Meissner P; Shukla SJ; Perumalswami PV; Weiss J; Wyatt BE; Schackman BR
J Public Health Manag Pract; 2019; 25(3):253-261. PubMed ID: 29975342
[TBL] [Abstract][Full Text] [Related]
15. Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011.
Drezner K; Bornschlegel K; McGibbon E; Balter S
Public Health Rep; 2013; 128(6):510-8. PubMed ID: 24179262
[TBL] [Abstract][Full Text] [Related]
16. Health Department Efforts to Increase Hepatitis C RNA Testing Among People Appearing Out of Care: Comparison of Outreach Approaches, New York City, 2017.
Webster R; Moore MS; Bocour A; Johnson N; Winters A
Public Health Rep; 2020; 135(6):823-830. PubMed ID: 32886566
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C infection in New York City, 2004.
Bornschlegel K; Berger M; Garg RK; Punsalang A; McKinney CM; Gwynn RC; Thorpe LE
J Urban Health; 2009 Nov; 86(6):909-17. PubMed ID: 19672718
[TBL] [Abstract][Full Text] [Related]
18. Health department-HIV clinic integration of data and human resources to re-engage out of care HIV-positive persons into clinical care in a New York City locale.
Udeagu C; Huang J; Eason L; Pickett L
AIDS Care; 2019 Nov; 31(11):1420-1426. PubMed ID: 30821484
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community.
Perumalswami PV; DeWolfe Miller F; Orabee H; Regab A; Adams M; Kapelusznik L; Aljibawi F; Pagano W; Tong V; Dieterich DT
Liver Int; 2014 Feb; 34(2):253-8. PubMed ID: 23890188
[TBL] [Abstract][Full Text] [Related]
20. Validation of Retention in HIV Care Status Using the New York City HIV Surveillance Registry and Clinical Care Data From a Large HIV Care Center.
Pati R; Robbins RS; Braunstein SL
J Public Health Manag Pract; 2017; 23(6):564-570. PubMed ID: 28079643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
